Crossmark

A Phase 1 Multiple Dose Study of Tirzepatide in Chinese Patients with Type 2 Diabetes

Published Online: 2023-06-07

Published Print: 2023-08

Authors

Feng, Ping

Sheng, Xiaoyan

Ji, Yongjia

Urva, Shweta

Wang, Feng

Miller, Sheila

Qian, Chenxi

An, Zhenmei

Cui, Yimin https://orcid.org/0000-0002-4186-1005
Clinical Trials ^BETA

Clinical trials referenced in this document:

nct04235959 at ClinicalTrials.gov

Documents that mention this clinical trial

A Phase 1 Multiple Dose Study of Tirzepatide in Chinese Patients with Type 2 Diabetes
https://doi.org/10.1007/s12325-023-02536-8
Funding

Funding for this research was provided by:

Eli Lilly and Company
License Information

Text and Data Mining valid from 2023-06-07

Version of Record valid from 2023-06-07
More Information

Article History

Received: 14 March 2023

Accepted: 28 April 2023

First Online: 7 June 2023

Document is current